The rapid influx of artificial intelligence solutions presents both a monumental opportunity and a significant challenge for healthcare systems tasked with ensuring patient safety and efficacy. To address this, Onboard AI has announced a strategic investment and collaboration with Cedars-Sinai. The partnership will deploy Onboard AI's automated governance platform to help the health system streamline and strengthen the evaluation, approval, and monitoring of AI solutions, enabling it to scale innovation responsibly.
Onboard AI announces a strategic investment and collaboration with Cedars-Sinai.
The partnership will deploy an AI-native governance platform for healthcare.
The platform automates the evaluation of AI solutions for safety, accuracy, and fairness.
It aims to reduce approval backlogs and ensure consistent, rigorous standards.
This addresses the challenge of managing dozens of AI solutions in a clinical setting.
The goal is to build trust and accelerate responsible AI adoption across the health system.
Hospitals are currently facing a flood of AI solutions from technology companies, each requiring meticulous checks to ensure they are safe, accurate, and effective across diverse clinical and operational environments. For many health systems, this has created a bottleneck characterized by manual reviews, long delays, and inconsistent processes that ultimately slow down the adoption of beneficial technologies. Onboard AI's platform is designed specifically to overcome this bottleneck by replacing outdated methods with automated, AI-native workflows.
The Onboard AI platform functions by using intelligent workflows to evaluate every AI solution against key criteria like safety, accuracy, fairness, and effectiveness. This automated approach moves beyond static checklists and manual reviews, leading to faster approvals, reduced backlogs, and the consistent application of high standards. Troy Bannister, CEO of Onboard AI, stated, “They chose us because we are AI-native, automated, and designed for both AI implementers and developers. Together, we're creating a system every healthcare organization can rely on to adopt AI responsibly and at scale.”
For Cedars-Sinai, which has already deployed dozens of AI solutions, this collaboration is a strategic step to manage the accelerating pace of technological innovation. The partnership is fundamentally about building a foundation of trust that allows for both rapid innovation and unwavering patient safety. Mouneer Odeh, Chief Data and AI Officer of Cedars-Sinai, emphasized this, saying, “Responsible AI isn't just about speed - it's about trust. With Onboard AI, we're scaling innovation by ensuring every solution meets our rigorous standards for safety and ethics. That's how we build confidence in the future of healthcare.”
This collaboration between a leading health system and a specialized AI governance provider marks a critical advancement in the digital transformation of healthcare. By implementing a scalable framework for responsible AI, Cedars-Sinai is positioning itself to harness the full potential of AI while maintaining the highest standards of patient care and safety.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.